Trinity University

Digital Commons @ Trinity
Chemistry Faculty Research

Chemistry Department

5-18-2011

Determining Protease Substrate Selectivity and
Inhibition by Label-Free Supramolecular Tandem
Enzyme Assays
Garima Ghale
Vijayakumar Ramalingam
Trinity University, vramalin@trinity.edu

Adam R. Urbach
Trinity University, aurbach@trinity.edu

Werner M. Nau

Follow this and additional works at: https://digitalcommons.trinity.edu/chem_faculty
Part of the Chemistry Commons
Repository Citation
Ghale, G., Ramalingam, V., Urbach, A. R., & Nau, W. M. (2011). Determining protease substrate selectivity and inhibition by labelfree supramolecular tandem enzyme assays. Journal of the American Chemical Society, 133(19), 7528-7535. doi: 10.1021/ja2013467

This Post-Print is brought to you for free and open access by the Chemistry Department at Digital Commons @ Trinity. It has been accepted for
inclusion in Chemistry Faculty Research by an authorized administrator of Digital Commons @ Trinity. For more information, please contact
jcostanz@trinity.edu.

Determining Protease Substrate Selectivity and Inhibition by
Label-free Supramolecular Tandem Enzyme Assays
Garima Ghale,§ Vijayakumar Ramalingam,† Adam R. Urbach,†,* and Werner M. Nau§,*
§

School of Engineering and Science, Jacobs University Bremen, Campus Ring 1, D-28759
Bremen, Germany, E-mail: w.nau@jacobs-university.de
†

Department of Chemistry, Trinity University, San Antonio, Texas 78218, U.S.A.,
E-mail: aurbach@trinity.edu

Abstract: An analytical method has been developed for the continuous monitoring of
protease activity on unlabelled peptides in real time by fluorescence spectroscopy. The assay
is enabled by a reporter pair comprising the macrocycle cucurbit[7]uril (CB7) and the
fluorescent dye acridine orange (AO). CB7 functions by selectively recognizing N-terminal
phenylalanine residues as they are produced during the enzymatic cleavage of enkephalintype peptides by the metalloendopeptidase thermolysin. The substrate peptides (e.g., ThrGly-Ala-Phe-Met-NH2) bind to CB7 with moderately high affinity (K ca. 104 M–1), while
their cleavage products (e.g., Phe-Met-NH2) bind very tightly (K > 106 M–1). AO signals the
reaction upon its selective displacement from the macrocycle by the high affinity product of
proteolysis. The resulting supramolecular tandem enzyme assay effectively measures the
kinetics of thermolysin, including the accurate determination of sequence specificity (Ser and
Gly instead of Ala), stereospecificity (DAla instead of LAla), endo- versus exopeptidase
activity (indicated by differences in absolute fluorescence response), and sensitivity to
terminal charges (-CONH2 versus -COOH). The capability of the tandem assay to measure
protease inhibition constants was demonstrated on phosphoramidon as a known inhibitor to
afford an inhibition constant of (17.8 ± 0.4) nM. This robust and label-free approach to the
study of protease activity and inhibition should be transferable to other endo- and
exopeptidases that afford products with N-terminal aromatic amino acids.
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Introduction
As the enzymes that catalyze the hydrolytic degradation of proteins, proteases are ubiquitous
in living systems and regulate a multitude of cellular processes including the cell cycle,
hormone activation, angiogenesis, and apoptosis.1-5 Aberrations in protease expression or
function are therefore implicated in many pathological conditions such as cancer,6 arthritis,7
and Alzheimer’s disease.8 In addition, proteases play an essential role in viral replication and
in the toxicity of bacteria.9 Indeed, the potential of proteases as targets for drug development
is enormous, as evidenced by the successful development of numerous therapeutics based on
protease inhibition.5
The characterization of protease activity for the purpose of determining substrate activity
and inhibitor potency is unfortunately slow and expensive. The vast majority of assays
require labeled substrates,10-17 which are costly and may not behave the same as their natural
counterparts.18 Label-free protease assays, on the other hand, rely on analytical instruments
such as mass spectrometry,18 or employ synthetic/semi-synthetic multifunctional pores,19,20
which are difficult to scale up for high-throughput screening. Hence, the development of
rapid and robust assays for protease activity greatly accelerates the characterization of
protease targets and the discovery of drug candidates.17,21
This paper describes a robust and convenient approach for measuring protease kinetics
using optical spectroscopy on label-free substrates and products. Our approach is based on a
supramolecular tandem assay,22-25 which incorporates an essential component of indicator–
displacement assays.26-28 Supramolecular tandem assay is a recently developed technique that
provides real-time continuous monitoring of enzymatic activity by following a change in the
concentration of substrate or product as it competitively displaces a fluorescent reporter dye
from the cavity of a macrocyclic host. These assays therefore rely on the differential binding
of the macrocycle with the fluorescent dye, the enzymatic substrate, and the corresponding
product.
Supramolecular tandem assays have been implemented successfully for monitoring
enzymatic transformations involving amino acids, biogenic amines, amino aldehydes, and
nucleotide phosphates.22-25 Until now, the technique was limited to substrates and products
which, owing to their low molecular weight, could essentially be fully immersed in the
macrocyclic host cavity, such that the entire analyte, e.g. arginine or cadaverine, served as
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recognition motif. Here, the utility of the tandem assay principle is transferred to peptides,
which themselves are far too large to be fully included in the macrocyclic cavity. Rather, it is
a residue of the peptide chain, namely an aryl ring, which complexes with differential affinity
to the macrocycle in the substrate and the product. For the first time, we demonstrate the
quantitative determination of absolute kinetic parameters (kcat/KM) for protease activity, the
application of this analysis to the profiling of enzyme substrates for sequence-selectivity,
stereospecificity, and endo- vs exopeptidase activity, as well as the quantitative determination
of inhibitory constants for protease inhibitors.

Figure 1. Amino acid sequences of the peptides used in this study; the N termini are
unprotected primary amines, the C termini are designated as -NH2 for a primary amide and OH for a carboxylic acid. The arrow indicates the cleavage site for thermolysin. Also shown
are the chemical structures of the macrocycle and fluorescent dye constituting the employed
reporter pair.
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Results and Discussion
Experimental Design. Cucurbit[7]uril (CB7, Figure 1) is a water-soluble macrocycle that
has been investigated extensively in biological applications including drug delivery,29-33
interactions with enzymes,34,35 plasma membrane protein fishing,36 and label-free enzyme
assays.22-25 The repeating glycoluril units produce a barrel-shaped container that has a
hydrophobic cavity and negatively charged portals.37 The latter are capable, not only for CB7
but also for its homologues, of binding inorganic cations as well as the cationic sites of
organic guests, mostly ammonium groups; nonpolar groups are preferentially immersed in
the inner cavity.38-42 CB7 and its larger homologue CB8 have been shown to bind aromatic
amino acids and sequence-specifically to peptides and proteins containing phenylalanine
(Phe), tryptophan (Trp), or tyrosine (Tyr) at the N-terminal positions.43-47 Recognition at the
N terminus is achieved via the cooperation of hydrophobic inclusion of the aromatic side
chain and electrostatic stabilization of the proximal N-terminal ammonium group.
The differential binding of CB7 to an aromatic residue located at the N terminus versus
other positions is exploited here in the design of an enzyme assay by choosing a protease
(thermolysin) that efficiently hydrolyzes the peptide bond on the amino side of phenylalanine
residues and thus generates an N-terminal phenylalanine as its product. The product binds to
CB7 more tightly than the starting material, and will, therefore, selectively displace a
fluorescent indicator from CB7. This allows real-time monitoring of the thermolysinmediated reaction by the pronounced change in fluorescence intensity. Thermolysin is a
thermally resistant (thermophilic) enzyme produced by Bacillus thermoproteolyticus. It is
selective for bulky, hydrophobic amino acids such as Phe and Leu,48 and represents the
family of thermolysin metalloendopeptidases as relevant therapeutic targets due to their high
substrate specificity, their functional role in extracellular transformations of neuroendocrine
as well as cardiovascular peptides, and in processes ranging from reproduction to
cardiovascular homeostasis.9,49,50
Enkephalin-based peptides were chosen as substrates to establish proof-of-principle for
the protease assay. These neurological pentapeptides of sequence Tyr-Gly-Gly-Phe-Met-OH
(natural amino and carboxy termini) or Tyr-Gly-Gly-Phe-Leu-OH are part of the endogenous
opioid system involved in pain perception and emotional behavior, and they are implicated in
the pathogenesis of Alzheimer's dementia.51 Thermolysin hydrolyzes these peptides at the
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Gly-Phe peptide bond, producing Phe-Met-OH and Phe-Leu-OH products that contain an Nterminal Phe and, thus, should bind to CB7 selectively versus the substrates as well as the
other peptide product fragments (Scheme 1).52-54

Scheme 1. CB7 binds selectively to N-terminal Phe residues due to cooperative hydrophobic
and ion-dipole interactions

The choice of the fluorescent dye is critical to the design of a supramolecular tandem
assay. Acridine orange (AO, Figure 1) and CB7 were selected as the “reporter pair” (i.e., the
macrocycle and dye pair). AO is a weakly fluorescent dye in aqueous solution, which
becomes strongly fluorescent upon encapsulation by CB7.55 Upon the addition (or enzymatic
formation) of a strongly binding analyte to the preformed CB7•AO complex, the fluorescence
intensity drops again, leading to a “switch-off” fluorescence response. Important to note, the
binding constant of CB7 with AO (2.9 × 105 M–1)24,55 lies in between the binding strength of
CB7 with the substrate and product of interest. This was demonstrated by simple titration
experiments (Figure 2 and Supporting Information), from which the binding constants of
peptides 1-9 were determined (Table 1). Peptides 1-6, the candidates to potentially act as
substrates for thermolysin, have invariably a low binding affinity to CB7, accounted by the
presence of only hydrophobic interaction between the amino acid Phe and the host cavity.
However, the corresponding proteolytic products (dipeptides 7-9) have 3 orders of magnitude
higher affinity for CB7 due to the additional electrostatic interaction between the N-terminal
ammonium group of Phe with the CB7 carbonyls. This high affinity disappears again for the
simple amino acid Phe (10), for which the adjacent C-terminal carboxylate group entirely
offsets the stabilizing interaction by the ammonium group. Note that the binding affinity of
CB7 between the peptides 1 and 2 is slightly different. Nevertheless, it is not surprising due
to the diastereomeric differentiation between L and D Ala by an achiral host CB7.56
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Figure 2. Fluorescence titrations (exc = 485 nm, obs = 510 nm) of substrates 1 and 6 and
their proteolysis products (dipeptides 7 and 9) by using competitive displacement of AO (0.5
μM) from CB7 (5 μM) in 10 mM ammonium phosphate buffer at pH 7.2, 37 C. The
titrations for the substrates are cut-off for clarity, see Supporting Information for more data.
I0 and I are the fluorescence intensities in the absence and presence of competitor,
respectively.

When compared to highly selective antibodies, the molecular recognition of peptides by
CB7 must be considered as rather unspecific. The synthetic macrocyclic host binds to all
pentapeptides 1-6 with very similar affinity, and even the binding constant of the amino acid
Phe (10) falls in the same range (Table 1). CB7 shows also little selectivity towards the
dipeptides 7-9. However, it differentiates the dipeptides 7-9 reliably from the pentapeptides
1-6, and this substrate/product differentiation is sufficient to set-up robust enzyme assays.
When thermolysin is added to the peptide solution containing an enkephalin-based substrate
6

and the CB7/AO reporter pair (Scheme 2), the enzymatic product, containing an N-terminal
phenylalanine residue, should rapidly (relative to the enzymatic transformation itself) and
competitively displace the AO dye from the CB7 cavity, thus yielding a decrease in
fluorescence intensity that reports the protease activity continuously and in real time. The
immediate response is due to the fast rates for the formation and dissociation of the
supramolecular assemblies, which, as previously discussed, constitutes an advantage of using
macrocycles instead of antibodies.24 As can be further seen from the actual titration plots
(Figure 2), even working at relatively low substrate concentrations of 5–20 M should
produce a readily detectable change in fluorescence response upon conversion of a substrate
to a product. This working concentration range is exactly desirable in protease assays,
including those employed in high-throughput screening for pharmaceutical investigations.14-17
Table 1: Binding constants (K) of peptides 1-9, phenylalanine 10, and phosphoramidon 11
with CB7 and proteolytic constants (kcat/KM) for their reaction with thermolysin.
Peptide sequence

K/(104 M–1)a

1

Thr-Gly-Ala-Phe-Met-NH2

1.3

14

2

Thr-Gly-DAla-Phe-Met-NH2

2.6

0.005c

3

Thr-Gly-Ala-Phe-Leu-NH2

0.35

3.2 [7.0]d

4

Thr-Gly-Ser-Phe-Met-NH2

1.9

6.9

5

Thr-Gly-Gly-Phe-Met-NH2

1.4

1.2

6

Thr-Gly-Ala-Phe-Leu-OH

0.18

2.3

7

Phe-Met-NH2

1500±500

e

8

Phe-Leu-NH2

2700±1500

e

9

Phe-Leu-OH

10

Phe-OH

2.0 [2.5] f

e

11

Phosphoramidon

0.12

g

Entry

a

210

kcat/KM(10–4 s–1 M–1)b

e

Determined by competitive fluorescence titrations, cf. Figure 2 and Supporting Information;

15% error unless explicitly stated. b Determined by supramolecular tandem assay at varying
peptide concentrations (5-55 M, n = 5-6), cf. Figure 3; kinetic parameters were determined
by nonlinear regression (see Supporting Information); 20% estimated error.
hydrolysis due to the presence of DAla.

d

c

Insignificant

Value in square brackets refers to exopeptidase

7

activity, see text and Supporting Information.e No conversion detected due to Phe N terminus.
f

In 0.1 M NaCl solution.56 g Phosphoramidon was employed as inhibitor, cf. Figure 5.
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Scheme 2. Product-selective fluorescence switch-off tandem assay using CB7 and AO as
reporter paira

a

It should be noted that the dye, substrate, and product are in rapid dynamic competitive
equilibrium for encapsulation within the CB7 macrocycle.

9

Enzyme Assays. To establish proof of principle for the use of a supramolecular tandem assay to
monitor protease activity on unlabelled peptides, we first investigated a series of enkephalin–
based peptides (Figure 1) with the sequence Thr-Gly-Ala-Phe-Met-NH2 (1), Thr-Gly-DAla-PheLeu-NH2 (2), Thr-Gly-Ala-Phe-Leu-NH2 (3), as well as the dipeptide product from proteolysis of
enkephalin 1, Phe-Met-NH2 (7).

Figure 3: (a) Continuous fluorescence assays (exc = 485 nm, obs = 510 nm) with the CB7/AO
reporter pair (8 M/ 0.5 M) upon addition of thermolysin (t = 0 min, 15 nM) to peptides 1-3
and 7 (30 M), at 37 °C. (b) Determination of enzyme kinetic parameters by monitoring of
thermolysin (15 nM) activity with varying concentration of enkephalin 1 (5–25 M) in 10 mM
ammonium phosphate buffer, pH 7.2, at 37 °C with the CB7/AO reporter pair (2.5 M/ 0.5 M).
I0 and I are the fluorescence intensities at t = 0 and t, respectively.
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As depicted in Figure 3a, peptides 1 and 3 were hydrolyzed rapidly, but peptide 2 showed
insignificant hydrolysis. The stark contrast in the rate of cleavage at the Ala-Phe bond for
peptides 1 and 2 was due to the substitution of LAla by its enantiomer. The tandem assay thus
reflects the previously established substrate selectivity of thermolysin, including the remarkable
stereospecificity of the P1 position.48,57-60 As can be also seen from Figure 3a, the dipeptide 7
shows no fluorescence response. This signifies that the peptide bond between Phe and Met in this
peptide is not cleaved by thermolysin (exopeptidase activity, see below). If it were cleaved, an
increase in fluorescence would have been observed, because the product (free Phe, 10) would
again constitute a weak competitor (see binding constants in Table 1). Again, it was known that
substrates lacking a peptide bond N-terminal to Phe (such as 7) are not digested by
thermolysin,53 such that our result established a negative control experiment.

Substrate Selectivity. Given the high sensitivity of the tandem assay observed in the initial
experiments, we decided to measure the kinetic behavior of thermolysin for substrates with
varying amino acids at the P1 position. With peptides 1 and 3 as parent compounds, the P1
mutations of Ala to Ser (peptide 4) and Ala to Gly (peptide 5) examined the effects of adding a
hydroxyl group to the  carbon, or removing the  carbon, respectively. Peptide 6 is an analogue
of 3 with a carboxylate at the C terminus, which was designed to test the effect of C-terminal
charge.
The enzyme-kinetic analysis required the determination of initial rates of reaction. For this
purpose, the observed fluorescence decay needed to be related to changes in absolute
concentration.25 This relationship was achieved by recording the fluorescence response obtained
by addition of a known quantity of an authentic sample of reaction product (see Supporting
Information). Analysis of the initial reaction rates at varying substrate concentrations (Figure 3b)
yielded the characteristic proteolytic constants (kcat/KM) for the different peptide sequences (inset
of Figure 3b and Table 1).61
Note that our tandem assays allow kinetic measurements for unlabeled peptides, while
previous assays were carried out with peptides carrying fluorescent labels such as 2naphthylamide (2NA)62 or dansyl.63 The structural differences prevent a direct comparison of the
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absolute proteolytic constants. Nevertheless, peptides 1 (kcat/KM = 14  104 M–1s–1) and 5 (1.5 
104 M–1s–1) showed the same order of magnitude as well as the same trends of substrate
selectivity as the labeled derivatives Glt-Gly-Ala-Phe-2NA (5.2  104 M–1s–1) and Glt-Gly-GlyPhe-2NA (0.15  104 M–1s–1),62 which was gratifying to observe.
The data in Table 1 show that the identity of the amino acid residue at the P1 position
significantly affects the proteolytic coefficients of thermolysin activity. The values are
moderately reduced for the peptides containing glycine and serine at P1 compared to their parent
compound 1 with alanine at P1 position. The binding of the substrate at P1 is governed by
hydrophobic interactions, which accounts for the fact that at P1, Gly and Ser are cleaved more
slowly than Ala.62,64,65 The use of a carboxyl group leads to a slight reduction in enzymatic
activity, as indicated by the kcat/KM value, presumably due to the known sensitivity of
thermolysin towards adjacent charges (see following section, note that most model substrates
were amidated at the C terminus for the convenience of peptide synthesis).

Exo- and Endopeptidase Behavior. During the determination of the kcat/KM values for the
peptides described above, we stumbled on the unexpected exopeptidase behavior of thermolysin
that was specific to the substrate Thr-Gly-Ala-Phe-Leu-NH2 (3). The expected endopeptidase
products of the cleavage of substrates Thr-Gly-Ala-Phe-Met-NH2 (1) and Thr-Gly-Ala-Phe-LeuNH2 (3) are Phe-Met-NH2 (7) and Phe-Leu-NH2 (8), respectively. These products bind tightly to
CB7 and are therefore responsible for the change in fluorescence intensity during the tandem
assay. Therefore, the final steady-state fluorescence response (i.e., after quantitative enzymatic
digestion of substrates 1 and 3) was expected to be similar to the fluorescence response brought
about by the same concentrations of their endopeptidase products 7 and 8. This similarity was
observed for substrate 1 but not for substrate 3.
In detail, the enzymatic hydrolysis of 5 M of the substrate Thr-Gly-Ala-Phe-Met-NH2 (1)
resulted in complete displacement of the dye from CB7, as observed by the similarity of the
steady-state fluorescence response after complete enzymatic conversion and the response of the
same concentration of Phe-Met-NH2 (Figures 4a and 4c). In the case of the substrate Thr-GlyAla-Phe-Leu-NH2 (3), however, the final steady-state fluorescence response upon enzymatic
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hydrolysis of 5 M substrate was less than that of its endopeptidase product Phe-Leu-NH2 (8) at
the same concentration (see Figure 4b & 4d). In fact, even a concentration of 10 M of substrate
3 was insufficient to produce the same fluorescence response as that produced by 5 M of 8. We
concluded that the expected product was not quantitatively formed. To account for this result,
and inspired by previous experimental observations,48,66,67 we suspected the possibility of
exopeptidase activity, i.e., enzymatic cleavage of the Phe-Leu peptide bond. We were exactly
able to corroborate this unusual pathway for peptide 3 by mass spectrometry (see Supporting
Information).
The observed exopeptidase cleavage leads to the formation of Thr-Gly-Ala-Phe-OH as
(another) product, one that is not further converted by thermolysin. Therefore, the yield of the
expected endopeptidase product (8), and the corresponding change in fluorescence response
upon the displacement of AO by 8, fall below expectation. In fact, the incomplete conversion,
signaled by the plateau being reached at higher fluorescence intensities, can be used to assess the
ratio of exo- versus endopeptidase cleavage (2.2:1), which, with the endopeptidase kinetics being
directly accessible (Figure 4 and Supporting Information), allows the projection of both rates.
This analysis affords a kcat/KM value of 3.2  104 M–1s–1 for the endopeptidase activity and a
value of 7.0  104 M–1s–1 for the exopeptidase activity. The higher proteolytic constant for the
hydrolysis of the Phe-Leu exo bond (i.e., Leu at P1' position) compared to the hydrolysis of the
Ala-Phe endo bond (i.e., Phe at P1') is consistent with the enzyme’s preference for hydrophobic
P1' residues, whereby increasing the hydrophobic residue from Leu to Phe increases the
interaction of the substrate with the active site of the enzyme, whilst decreasing the catalytic
efficiency,60,68,69 thereby accounting for the observed lower kcat/KM value for the endo cleavage.
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Figure 4: Fluorescence measurements using CB7/AO (2.5 M CB7 and 0.5 M AO, exc = 485
nm, obs = 510 nm) as a reporter pair in 10 mM ammonium phosphate buffer, pH 7.2, at 37 °C.
Competitive fluorescence titration plots of a) Phe-Met-NH2 (8) and b) Phe-Leu-NH2 (9). Tandem
protease assays for thermolysin (15 nM) with substrates c) Thr-Gly-Ala-Phe-Met-NH2 (1) and d)
Thr-Gly-Ala-Phe-Leu-NH2 (3).

It is interesting that we observed no exopeptidase activity for the non-amidated peptide ThrGly-Ala-Phe-Leu-OH (6), as confirmed by the plateau region of the fluorescence trace as well as
by mass spectrometry (see Supporting Information). This result reveals that the C-terminal
charge of the peptide directs endo- versus exopeptidase activity, at least for substrates containing
bulky hydrophobic residues (Phe and Leu) at the P1' position. Conversely, a comparison of
substrate 3 (exopeptidase cleavage observed) with its product 8, for which no conversion by
themolysin is observed (Figure 3a and Supporting Information), further exposes that an N14

terminal charge directly at phenylalanine suppresses the exopeptidase activity of thermolysin.
This observed sensitivity of thermolysin toward adjacent charges supports prior claims based on
studies performed by alternative assays with labeled substrates.48,66,67
As can be seen from these studies, our label-free protease tandem assay provides information
not only on the enzymatic activity, kinetics, and substrate selectivity, but also on the
chemoselectivity of the proteolytic cleavage, because the plateau region after quantitative
conversion is a signature for the identity of the expected product and thus enables direct
quantification of the extent of the expected reaction.

Protease Inhibition. Having established the capability of the assay to effectively measure the
kinetics of thermolysin activity, we sought to apply the assay to the determination of enzyme
inhibition, which is critical to the evaluation of drug candidates. Using Thr-Gly-Ala-Phe-MetNH2 (1) as the model substrate, inhibition studies for thermolysin were carried out using the
product-selective tandem assay principle and the inhibitor phosphoramidon (11), a naturally
occurring, potent inhibitor of thermolysin.70-73 Inhibitors can hypothetically interfere with the
assay principle by binding to the macrocycle.24 Fortunately, this can be readily tested by
competitive titrations, which afforded a low binding constant for 11 (1200 M–1, Table 1). In the
concentration range relevant for studies with potent inhibitors (up to 100 nM), binding of 11 to
CB7 (< 0.3%) can therefore be safely neglected.
As is typical for competitive inhibitors, we observed that increasing the concentration of 11
decreases the rate of thermolysin hydrolysis via dynamic competition with the substrate for
binding to the enzyme, and yet allows the irreversible peptidase reaction on the enzyme•substrate
complex to proceed to completion, as observed by similar steady-state fluorescence intensities at
all concentrations of inhibitor (Figure 5). The change in initial rates of decrease in fluorescence
intensity was used to calculate a Ki value of (17.8 ± 0.4) nM,74 which falls right into the reported
range (3.5 – 60 nM), all determined under slightly varying experimental conditions and with
different assay methods employing fluorescently labeled substrates.70,71,75
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Figure 5: Determination of thermolysin (15 nM) inhibition by phosphoramidon (11, 0–100 nM)
in the presence of 10 M Thr-Gly-Ala-Phe-Met-NH2 (1) by using the CB7/AO (0.5 M/ 2.5 M)
reporter pair in 10 mM ammonium phosphate, pH 7.2, at 37 C. a) Continuous fluorescence
traces (exc = 485 nm, obs = 510 nm) upon addition of 10 M Thr-Gly-Ala-Phe-Met-NH2 (1) for
the determination of the initial rates. b) Corresponding dose-response curve for inhibition of
thermolysin by phosphoramidon (11).

Conclusions
The addition of macrocyclic host molecules in combination with fluorescent dyes establishes a
label-free method for the real-time, continuous monitoring of protease activity by fluorescence
spectroscopy. Protease assays using unmodified substrates are important because they enable the
detailed characterization of the natural substrate selectivity of a target protease as well as its
activity in the presence of inhibitors. We have successfully applied the tandem assay principle to
the continuous monitoring of the hydrolysis of enkephalin-based peptides by thermolysin. In
doing so, we have established proof-of-principle for the use of cucurbituril-based fluorescent
reporter pairs for proteases. The general selectivity of macrocycles (even if moderate in
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comparison to specific receptors) renders potentially broad transferability of this assay to other
exo– and endo–peptidases. Furthermore, for the first time, we have extended the applicability of
tandem assays towards an in–depth profiling of enzyme activity for a wide range of substrates,
towards sensing enzyme substrate stereospecificity, and have demonstrated the potential of this
assay for the screening of inhibitors. These applications of tandem assays to monitor proteolytic
activity have significant implications for drug design as well as medical diagnostics, where
proteases are important disease markers.

Experimental Section
Materials. Peptides 1-8 were synthesized by standard Fmoc solid-phase synthesis protocols on
Rink amide MBHA resin (for C-terminal amides) or Wang acid resin (for peptide 6 containing a
C-terminal carboxylic acid) and purified by reversed phase HPLC. Purity was verified by
reversed phase analytical HPLC and

1

H NMR spectroscopy. Identity was verified by

electrospray mass spectrometry.
Peptide Phe-Leu-OH (9) and amino acid Phe-OH (10) were used as received from Bachem
and Applichem respectively. Cucurbit[7]uril (CB7) was synthesized according to the literature.7678

Acridine orange (AO), thermolysin (lyophilized powder, 36.5 U/mg) and phosphoramidon

were used as received from Sigma-Aldrich.

Methods.

Absorbance

measurements

were

performed

with

a

Varian

Cary

4000

spectrophotometer. The concentrations of peptides 1-10 were determined assuming the
extinction coefficient of free phenylalanine at 257 nm, 257 = 195 M–1cm–1.79 For thermolysin and
phosphoramidon, 280 = 61100 M–1cm–1 and 280 = 5500 M–1cm–1, respectively, were used.63,71 A
Varian Eclipse spectrofluorimeter was used for steady-state fluorescence measurements and for
the enzyme assays.
Continuous assays were performed with 0-55 M peptide, 2.5 M CB7 and 0.5 M AO (exc
= 485 nm, obs = 510 nm) in 10 mM ammonium buffer, pH 7.2, in a variable-temperature cell
holder at 37.0 ± 0.1 °C, and the reaction was initiated by addition of thermolysin (15 nM). For
the inhibition studies, the mixture of thermolysin (10 nM) and phosphoramidon (0-100 nM) was
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pre-incubated for 15 minutes at 37.0 ± 0.1 °C in the presence of the reporter pair and the reaction
was initiated by addition of 10 M Thr-Gly-Ala-Phe-Met-NH2 (1).
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Supporting Information. Fluorescence titration plots of peptide substrates, details on the
calculations of the enzymatic reaction rates, mass spectra, and supporting evidence for the
exopeptidase activity are available in the Supporting Information file. This information is
available free of charge via the Internet at http://pubs.acs.org.
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